retatrutide peptide vs tirzepatide Triple G,” also known as retatrutide, represents the next generation of subcutaneous therapies for metabolic disease. Exciting advancements! Thanks for posting Dr Brian! Semaglutide vs Tirzepatide vs Retatrutide:

Sigalos, J

These benefits appear to extend even to people without diabetes who have a history of cardiovascular disease

Ozempic and Fertility GLP-1 drugs are approved by the U.S

Serious safety concerns are rare but include: Systemic infections : Immunocompromised individuals, those with central venous catheters, or patients with damaged gut barriers face increased risk of bacteremia or fungemia from probiotic organisms [19] [20] Antibiotic resistance transfer : Some probiotic strains may carry antibiotic resistance genes Metabolic complications : Rare cases of D-lactic acidosis have been reported with high-dose probiotic use [25] Specific populations requiring caution include patients with severe acute pancreatitis (based on the PROPATRIA trial showing increased mortality), short bowel syndrome, immunosuppression (HIV/AIDS, chemotherapy, organ transplant recipients), and critically ill individuals

The dual mechanism of tirzepatide produces greater average weight loss in clinical trials, approximately 22% body weight versus 15% for semaglutide